Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05419817
Title Pembrolizumab With Sitravatinib in Recurrent Endometrial Cancer and Other Solid Tumors With Deficient Mismatch Repair System
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Haider Mahdi
Age Groups: senior | adult
Covered Countries

Additional content available in CKB BOOST